Epigral Limited is a major player in the Indian chemical industry, specializing in chlor-alkali products and derivatives like CPVC Resin and Epichlorohydrin.

In Q2FY26, the company's revenue fell by 4%, and EBITDA margins decreased to 23% from 27% due to lower product realizations and sales volume.

Epigral is expanding its CPVC and Epichlorohydrin capacity and launching a new Wind-Solar Hybrid power plant, reinforcing its market dominance and commitment to sustainable energy.

The company experienced a sales volume drop in H1FY26, attributed primarily to seasonal downturns, but positive momentum is expected in H2FY26 with improved plant utilization post-monsoon.

Epigral is focused on its derivative and specialty chemical segments, aiming for a 70% revenue contribution from these areas by FY2028.